Hyperion Therapeutics Inc (NASDAQ:HPTX)

45.90
Delayed Data
As of Mar 31
 -0.08 / -0.17%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.25%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sofinnova Ventures Inc
Sale6/04/2014417,747$27.70$11.6M+56.60%
Sofinnova Ventures Inc
Sale6/04/2014417,747$27.70$11.6M+56.60%
Scharschmidt Bruce F
Chief Medical Officer & Senior Vice President
Sale2/27/201524,996$29.79$744.6K+55.33%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/17/201510,000$37.56$375.6K+14.66%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/10/201510,000$35.08$350.8K+39.85%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/09/20155,650$29.32$165.7K+53.72%
Scharschmidt Bruce F
Chief Medical Officer & Senior Vice President
Sale2/27/20154,804$30.43$146.2K+55.33%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale3/09/20152,800$30.00$84.0K+53.72%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale1/20/20152,500$25.27$63.2K+82.87%
Nash Christine A
Chief Commercial Officer & Senior Vice President
Sale1/20/20152,500$24.36$60.9K+82.87%
Page of 6

To view my watchlist

Not a member yet?

Sign up now for a free account